New molecular studies have delivered quite a few insights in to the procedures that govern the development and progression of CLL, which include quite a few novel mutated genes clustered in numerous functional pathways. The CLL epigenome is reprogrammed with the modulation of regulatory locations that surface de novoGenetic susceptibility mechanism